Startup Tests Psychedelic-Inspired Drug for Parkinson's

A new biotech company is launching trials for a psychedelic-like drug that could ease Parkinson's symptoms without the hallucinogenic effects.

The breakthrough approach offers fresh hope for millions living with the movement disorder.